A detailed history of Edgestream Partners, L.P. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Edgestream Partners, L.P. holds 2,202 shares of VRTX stock, worth $898,812. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,202
Previous 2,666 17.4%
Holding current value
$898,812
Previous $1.25 Million 18.01%
% of portfolio
0.05%
Previous 0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$460.0 - $505.78 $213,440 - $234,681
-464 Reduced 17.4%
2,202 $1.02 Million
Q2 2024

Aug 09, 2024

SELL
$392.81 - $485.53 $3.92 Million - $4.85 Million
-9,988 Reduced 78.93%
2,666 $1.25 Million
Q1 2024

May 10, 2024

BUY
$407.69 - $446.08 $4.85 Million - $5.31 Million
11,908 Added 1596.25%
12,654 $5.29 Million
Q4 2023

Feb 14, 2024

SELL
$343.0 - $410.68 $911,008 - $1.09 Million
-2,656 Reduced 78.07%
746 $303,000
Q3 2023

Nov 14, 2023

BUY
$338.18 - $362.46 $332,092 - $355,935
982 Added 40.58%
3,402 $1.18 Million
Q2 2023

Aug 10, 2023

BUY
$314.42 - $351.91 $760,896 - $851,622
2,420 New
2,420 $851,000
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $630,630 - $703,635
2,303 Added 83.29%
5,068 $1.47 Million
Q2 2022

Aug 12, 2022

BUY
$234.96 - $292.55 $649,664 - $808,900
2,765 New
2,765 $779,000
Q1 2022

May 13, 2022

SELL
$221.42 - $260.97 $322,608 - $380,233
-1,457 Closed
0 $0
Q4 2021

Feb 15, 2022

SELL
$177.01 - $223.45 $615,109 - $776,488
-3,475 Reduced 70.46%
1,457 $320,000
Q3 2021

Nov 15, 2021

BUY
$181.39 - $202.99 $894,615 - $1 Million
4,932 New
4,932 $895,000
Q2 2019

Aug 08, 2019

SELL
$164.61 - $190.37 $1.24 Million - $1.44 Million
-7,540 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$163.73 - $194.7 $1.23 Million - $1.47 Million
7,540 New
7,540 $1.39 Million
Q3 2018

Nov 07, 2018

SELL
$167.73 - $192.74 $1.31 Million - $1.5 Million
-7,789 Closed
0 $0
Q2 2018

Aug 09, 2018

BUY
$145.72 - $169.96 $1.14 Million - $1.32 Million
7,789 New
7,789 $1.32 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Edgestream Partners, L.P. Portfolio

Follow Edgestream Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.